Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.03 – $2.79
1% from low
No one on the platform currently holds IOBT.
No tracked institution reports a position in IOBT as of their last filing.
No one on the platform has traded IOBT yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $14M | +1375.4% | $-0.29 | $-0.29–$-0.29 | — | 1 |
| 2027 | $18M | +28.6% | $-0.31 | $-0.31–$-0.31 | — | 1 |
| 2028 | $54M | +203.4% | $-0.19 | $-0.25–$-0.13 | — | 2 |
| 2029 | $146M | +169.6% | $-0.04 | $-0.04–$-0.04 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-11-14 | $-0.31 | $-0.28 | +9.7% |
| 2025-08-14 | $-0.35 | $-0.40 | -14.3% |
| 2025-05-14 | $-0.45 | $-0.34 | +24.4% |
| 2025-03-25 | $-0.38 | $-0.48 | -25.2% |
| 2024-11-12 | $-0.29 | $-0.36 | -24.1% |
| 2024-08-13 | $-0.34 | $-0.31 | +8.8% |
| 2024-05-14 | $-0.37 | $-0.30 | +18.9% |
| 2024-03-05 | $-0.36 |
| $-0.40 |
| -11.1% |
| $55M |
| — |
| KPTIKaryopharm Therapeutics Inc. | $1.99 | -1.97% | $45M | — |
| NRXPNRx Pharmaceuticals, Inc. | $3.34 | -0.60% | $58M | — |
Source: Financial Modeling Prep · peers by sector/industry